PET scans to aid Hodgkin treatment

PET scans can successfully be used to assess whether patients with Hodgkin lymphoma need additional drug treatment, according to a new study published last night.

The British-led project used PET scanning to assess some 1,200 patients after two cycles of standard chemotherapy to see whether they seemed clear of disease.

The researchers then tested the need for the drug bleomycin in the next course of chemotherapy.

Bleomycin has been in used for 30 years but can scar the lungs, causing severe problems.

Patients found to be clear in the scan were divided in to two groups, one to receive bleomycin and the others to be spared the drug. Other patients went on to have intensive chemotherapy.

The study showed that both groups of patients had the same survival rates – but those who did not receive bleomycin were spared the drug’s side-effects, according to the findings, published in the New England Journal of Medicine. Overall survival rates after three years were about 95%.

The research included the UK, Europe and Australasia and was run from the Cancer Research UK and UCL Cancer Trails Centre, London.

Researcher Professor Peter Johnson, of Southampton University, said: “As we’ve done in this trial, personalising treatment based on how well it works is a major development for patients with Hodgkin lymphoma, and sets a new standard of care.

“Knowing which patients have a more difficult to treat form of the disease means we can select those who need stronger chemotherapy, while sparing everyone else the severe side effects such as infertility.

"This approach, along with a reduction in the need for radiotherapy, should substantially reduce damage to healthy tissues and the risk of second cancers caused by treatments.”

Johnson P. et al. Adapted treatment guided by interim PET scan in advanced Hodgkin’s Lymphoma NEJM 22 June 2016

,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index